nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—nerve—hypothyroidism	0.0917	0.561	CbGeAlD
Fosaprepitant—TACR1—adrenal gland—hypothyroidism	0.0254	0.155	CbGeAlD
Fosaprepitant—TACR1—blood—hypothyroidism	0.0254	0.155	CbGeAlD
Fosaprepitant—TACR1—testis—hypothyroidism	0.021	0.128	CbGeAlD
Fosaprepitant—Wheezing—Levothyroxine—hypothyroidism	0.021	0.0294	CcSEcCtD
Fosaprepitant—Wheezing—Dextrothyroxine—hypothyroidism	0.021	0.0294	CcSEcCtD
Fosaprepitant—Disorientation—Dextrothyroxine—hypothyroidism	0.0175	0.0245	CcSEcCtD
Fosaprepitant—Disorientation—Levothyroxine—hypothyroidism	0.0175	0.0245	CcSEcCtD
Fosaprepitant—Hypertension—Liothyronine—hypothyroidism	0.0166	0.0232	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0154	0.126	CbGpPWpGaD
Fosaprepitant—Wheezing—Liotrix—hypothyroidism	0.0154	0.0216	CcSEcCtD
Fosaprepitant—Hypotension—Liothyronine—hypothyroidism	0.0147	0.0205	CcSEcCtD
Fosaprepitant—Muscular weakness—Dextrothyroxine—hypothyroidism	0.0138	0.0194	CcSEcCtD
Fosaprepitant—Muscular weakness—Levothyroxine—hypothyroidism	0.0138	0.0194	CcSEcCtD
Fosaprepitant—Disorientation—Liotrix—hypothyroidism	0.0129	0.018	CcSEcCtD
Fosaprepitant—Body temperature increased—Liothyronine—hypothyroidism	0.0124	0.0174	CcSEcCtD
Fosaprepitant—Weight decreased—Levothyroxine—hypothyroidism	0.0123	0.0172	CcSEcCtD
Fosaprepitant—Weight decreased—Dextrothyroxine—hypothyroidism	0.0123	0.0172	CcSEcCtD
Fosaprepitant—TACR1—Peptide GPCRs—TSHR—hypothyroidism	0.0122	0.0998	CbGpPWpGaD
Fosaprepitant—Hypokalaemia—Liotrix—hypothyroidism	0.0105	0.0147	CcSEcCtD
Fosaprepitant—Muscular weakness—Liotrix—hypothyroidism	0.0102	0.0142	CcSEcCtD
Fosaprepitant—Flushing—Levothyroxine—hypothyroidism	0.0101	0.0141	CcSEcCtD
Fosaprepitant—Flushing—Dextrothyroxine—hypothyroidism	0.0101	0.0141	CcSEcCtD
Fosaprepitant—Abdominal distension—Liotrix—hypothyroidism	0.01	0.014	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00994	0.0814	CbGpPWpGaD
Fosaprepitant—Weight decreased—Liotrix—hypothyroidism	0.00902	0.0126	CcSEcCtD
Fosaprepitant—Angioedema—Dextrothyroxine—hypothyroidism	0.00862	0.0121	CcSEcCtD
Fosaprepitant—Angioedema—Levothyroxine—hypothyroidism	0.00862	0.0121	CcSEcCtD
Fosaprepitant—Palpitations—Dextrothyroxine—hypothyroidism	0.00834	0.0117	CcSEcCtD
Fosaprepitant—Palpitations—Levothyroxine—hypothyroidism	0.00834	0.0117	CcSEcCtD
Fosaprepitant—Anxiety—Levothyroxine—hypothyroidism	0.00801	0.0112	CcSEcCtD
Fosaprepitant—Anxiety—Dextrothyroxine—hypothyroidism	0.00801	0.0112	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Liotrix—hypothyroidism	0.00794	0.0111	CcSEcCtD
Fosaprepitant—Shock—Dextrothyroxine—hypothyroidism	0.00758	0.0106	CcSEcCtD
Fosaprepitant—Shock—Levothyroxine—hypothyroidism	0.00758	0.0106	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00745	0.0104	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00745	0.0104	CcSEcCtD
Fosaprepitant—Flushing—Liotrix—hypothyroidism	0.0074	0.0104	CcSEcCtD
Fosaprepitant—Insomnia—Levothyroxine—hypothyroidism	0.00697	0.00975	CcSEcCtD
Fosaprepitant—Insomnia—Dextrothyroxine—hypothyroidism	0.00697	0.00975	CcSEcCtD
Fosaprepitant—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00687	0.00961	CcSEcCtD
Fosaprepitant—Dyspnoea—Levothyroxine—hypothyroidism	0.00687	0.00961	CcSEcCtD
Fosaprepitant—Flatulence—Liotrix—hypothyroidism	0.00684	0.00958	CcSEcCtD
Fosaprepitant—Dysgeusia—Liotrix—hypothyroidism	0.0068	0.00952	CcSEcCtD
Fosaprepitant—Fatigue—Levothyroxine—hypothyroidism	0.00664	0.0093	CcSEcCtD
Fosaprepitant—Fatigue—Dextrothyroxine—hypothyroidism	0.00664	0.0093	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—TRH—hypothyroidism	0.00652	0.0534	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00644	0.0527	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00635	0.00889	CcSEcCtD
Fosaprepitant—Feeling abnormal—Levothyroxine—hypothyroidism	0.00635	0.00889	CcSEcCtD
Fosaprepitant—Angioedema—Liotrix—hypothyroidism	0.00634	0.00888	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.0063	0.00882	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.0063	0.00882	CcSEcCtD
Fosaprepitant—Syncope—Liotrix—hypothyroidism	0.00623	0.00872	CcSEcCtD
Fosaprepitant—Palpitations—Liotrix—hypothyroidism	0.00614	0.00859	CcSEcCtD
Fosaprepitant—Urticaria—Dextrothyroxine—hypothyroidism	0.00612	0.00857	CcSEcCtD
Fosaprepitant—Urticaria—Levothyroxine—hypothyroidism	0.00612	0.00857	CcSEcCtD
Fosaprepitant—Loss of consciousness—Liotrix—hypothyroidism	0.0061	0.00854	CcSEcCtD
Fosaprepitant—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00609	0.00852	CcSEcCtD
Fosaprepitant—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00609	0.00852	CcSEcCtD
Fosaprepitant—Abdominal pain—Levothyroxine—hypothyroidism	0.00609	0.00852	CcSEcCtD
Fosaprepitant—Body temperature increased—Levothyroxine—hypothyroidism	0.00609	0.00852	CcSEcCtD
Fosaprepitant—Hypertension—Liotrix—hypothyroidism	0.00599	0.00839	CcSEcCtD
Fosaprepitant—Chest pain—Liotrix—hypothyroidism	0.00591	0.00827	CcSEcCtD
Fosaprepitant—Anxiety—Liotrix—hypothyroidism	0.00589	0.00825	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00583	0.0477	CbGpPWpGaD
Fosaprepitant—Anaphylactic shock—Liotrix—hypothyroidism	0.00567	0.00793	CcSEcCtD
Fosaprepitant—Oedema—Liotrix—hypothyroidism	0.00567	0.00793	CcSEcCtD
Fosaprepitant—Infection—Liotrix—hypothyroidism	0.00563	0.00788	CcSEcCtD
Fosaprepitant—Shock—Liotrix—hypothyroidism	0.00557	0.0078	CcSEcCtD
Fosaprepitant—Asthenia—Dextrothyroxine—hypothyroidism	0.00553	0.00774	CcSEcCtD
Fosaprepitant—Asthenia—Levothyroxine—hypothyroidism	0.00553	0.00774	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Liotrix—hypothyroidism	0.00548	0.00767	CcSEcCtD
Fosaprepitant—Pruritus—Levothyroxine—hypothyroidism	0.00545	0.00763	CcSEcCtD
Fosaprepitant—Pruritus—Dextrothyroxine—hypothyroidism	0.00545	0.00763	CcSEcCtD
Fosaprepitant—Hypotension—Liotrix—hypothyroidism	0.00529	0.00741	CcSEcCtD
Fosaprepitant—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00527	0.00738	CcSEcCtD
Fosaprepitant—Diarrhoea—Levothyroxine—hypothyroidism	0.00527	0.00738	CcSEcCtD
Fosaprepitant—Insomnia—Liotrix—hypothyroidism	0.00513	0.00717	CcSEcCtD
Fosaprepitant—Dyspnoea—Liotrix—hypothyroidism	0.00505	0.00707	CcSEcCtD
Fosaprepitant—Decreased appetite—Liotrix—hypothyroidism	0.00493	0.0069	CcSEcCtD
Fosaprepitant—Vomiting—Levothyroxine—hypothyroidism	0.0049	0.00686	CcSEcCtD
Fosaprepitant—Vomiting—Dextrothyroxine—hypothyroidism	0.0049	0.00686	CcSEcCtD
Fosaprepitant—Fatigue—Liotrix—hypothyroidism	0.00489	0.00684	CcSEcCtD
Fosaprepitant—Rash—Levothyroxine—hypothyroidism	0.00486	0.0068	CcSEcCtD
Fosaprepitant—Rash—Dextrothyroxine—hypothyroidism	0.00486	0.0068	CcSEcCtD
Fosaprepitant—Dermatitis—Dextrothyroxine—hypothyroidism	0.00485	0.00679	CcSEcCtD
Fosaprepitant—Dermatitis—Levothyroxine—hypothyroidism	0.00485	0.00679	CcSEcCtD
Fosaprepitant—Constipation—Liotrix—hypothyroidism	0.00485	0.00678	CcSEcCtD
Fosaprepitant—Headache—Dextrothyroxine—hypothyroidism	0.00483	0.00676	CcSEcCtD
Fosaprepitant—Headache—Levothyroxine—hypothyroidism	0.00483	0.00676	CcSEcCtD
Fosaprepitant—Feeling abnormal—Liotrix—hypothyroidism	0.00467	0.00654	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Liotrix—hypothyroidism	0.00463	0.00649	CcSEcCtD
Fosaprepitant—Nausea—Levothyroxine—hypothyroidism	0.00458	0.00641	CcSEcCtD
Fosaprepitant—Nausea—Dextrothyroxine—hypothyroidism	0.00458	0.00641	CcSEcCtD
Fosaprepitant—Urticaria—Liotrix—hypothyroidism	0.0045	0.0063	CcSEcCtD
Fosaprepitant—Abdominal pain—Liotrix—hypothyroidism	0.00448	0.00627	CcSEcCtD
Fosaprepitant—Body temperature increased—Liotrix—hypothyroidism	0.00448	0.00627	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00432	0.0353	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Liotrix—hypothyroidism	0.00417	0.00584	CcSEcCtD
Fosaprepitant—Asthenia—Liotrix—hypothyroidism	0.00407	0.00569	CcSEcCtD
Fosaprepitant—Pruritus—Liotrix—hypothyroidism	0.00401	0.00561	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00396	0.0324	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Liotrix—hypothyroidism	0.00388	0.00543	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00385	0.0315	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00385	0.0315	CbGpPWpGaD
Fosaprepitant—Dizziness—Liotrix—hypothyroidism	0.00375	0.00525	CcSEcCtD
Fosaprepitant—Vomiting—Liotrix—hypothyroidism	0.0036	0.00504	CcSEcCtD
Fosaprepitant—Rash—Liotrix—hypothyroidism	0.00357	0.005	CcSEcCtD
Fosaprepitant—Dermatitis—Liotrix—hypothyroidism	0.00357	0.005	CcSEcCtD
Fosaprepitant—Headache—Liotrix—hypothyroidism	0.00355	0.00497	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—AVP—hypothyroidism	0.00342	0.028	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00338	0.0277	CbGpPWpGaD
Fosaprepitant—Nausea—Liotrix—hypothyroidism	0.00337	0.00471	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—TRH—hypothyroidism	0.00329	0.0269	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00306	0.0251	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—TSHB—hypothyroidism	0.00293	0.024	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—TSHR—hypothyroidism	0.00293	0.024	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00227	0.0186	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00225	0.0184	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TRH—hypothyroidism	0.00186	0.0152	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—AVP—hypothyroidism	0.00173	0.0141	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TRH—hypothyroidism	0.00169	0.0138	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00166	0.0136	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00166	0.0136	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00151	0.0123	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TSHB—hypothyroidism	0.0015	0.0123	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TSHR—hypothyroidism	0.0015	0.0123	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CLTC—hypothyroidism	0.00115	0.00944	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—hypothyroidism	0.00115	0.00939	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—VAV3—hypothyroidism	0.00101	0.00829	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TRH—hypothyroidism	0.000997	0.00816	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AVP—hypothyroidism	0.000976	0.00799	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—VAV3—hypothyroidism	0.00092	0.00753	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TSHB—hypothyroidism	0.000888	0.00727	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TSHR—hypothyroidism	0.000888	0.00727	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AVP—hypothyroidism	0.000886	0.00725	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SH2B3—hypothyroidism	0.000792	0.00648	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—hypothyroidism	0.000649	0.00531	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—hypothyroidism	0.000589	0.00482	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRL—hypothyroidism	0.000587	0.00481	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VAV3—hypothyroidism	0.000543	0.00445	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AVP—hypothyroidism	0.000524	0.00429	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—hypothyroidism	0.000348	0.00285	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IGF1—hypothyroidism	0.000335	0.00274	CbGpPWpGaD
